Published in

De Gruyter, Drug Metabolism and Personalized Therapy, 1(32), 2017

DOI: 10.1515/dmpt-2016-0040

Links

Tools

Export citation

Search in Google Scholar

Influence of genetic polymorphisms of CYP3A5 and ABCB1 on sirolimus pharmacokinetics, patient and graft survival and other clinical outcomes in renal transplant

This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

AbstractBackground:In transplant patients receivingMethods:Forty-eight renal transplant recipients (suffered 48% diabetes mellitus, 91% hypertension, and 47% dyslipidemia) were genotyped forResults:1/Conclusions:and